Researchers have introduced a novel diagnostics method that can more sensitively detect gene fusions in B-cell acute lymphoblastic leukemia, the most common type of pediatric cancer.
The tool enables a higher diagnostic yield from low-coverage, low-cost sequencing, making it a promising solution for pediatric leukemia diagnosis.
The novel method is compared to conventional B-cell acute lymphoblastic leukemia fusion diagnostics, showing improved sensitivity and accuracy.
The tool's ability to detect gene fusions with high precision and low cost makes it a valuable asset in the fight against pediatric cancer.
The research was published in a peer-reviewed publication, ensuring the credibility and reliability of the findings.
